Canton Strategic Holdings, Inc. (THAR)
NASDAQ
Closed
Oct 20, 2026
Day's Range
1.6752 wk Range
1.66Overview - THAR - Canton Strategic Holdings, Inc.
Key Statistics
Valuation
Enterprise Value
166.05M
P/E (Trailing)
‪0.02‬
P/E (Forward)
‪-39.50‬
PEG Ratio
‪-39.50‬
Price / Book
‪5.55‬
EV / EBITDA
‪-3.94‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-99.79%‬
Return on Equity
‪-225.00%‬
Ownership
Shares Outstanding
37.38M
Float
28.89M
Short % of Shares Outstanding
‪6.72%‬
Held by Insiders
‪22.65%‬
Held by Institutions
‪22.23%‬
Price stats
Beta
‪1.45‬
50-Day Avg
‪3.47‬
200-Day Avg
‪2.73‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Market Cap - THAR - Canton Strategic Holdings, Inc.
Peers - THAR - Canton Strategic Holdings, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- THARNASDAQCanton Strategic Holdings, Inc.68.38MMarket Cap-72.83%52-week change0.02P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.03BMarket Cap-23.08%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.82BMarket Cap+8.90%52-week change17.26P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - THAR - Canton Strategic Holdings, Inc.
About
Canton Strategic Holdings, Inc. is a U.S.-based public company focused on two distinct operating areas: digital asset treasury activities tied to the Canton Network and clinical-stage biotechnology research and development. The company works to support institutional blockchain adoption through the use of Canton Coin,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
